N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells

Theranostics. 2021 May 3;11(14):6786-6799. doi: 10.7150/thno.59703. eCollection 2021.

Abstract

Rationale: Bone marrow-derived mesenchymal stem cells (BM-MSCs) recruited into breast tumors regulate the behavior of tumor cells via various mechanisms and affect clinical outcomes. Although signaling molecules, such as transforming growth factor β (TGF-β), are known to transmit signals between BM-MSCs and breast tumor cells for recruiting BM-MSCs, it is unclear which specific intrinsic molecules involved in cell motility mediate the migration of BM-MSCs into breast tumor. It is also unclear as to how specific intrinsic molecules contribute to the migration. Methods: Conditioned medium (CM) from breast tumor cells (MCF-7 and MDA-MB-231) that simulates breast tumor secreting TGF-β was used to examine the migration of BM-MSCs into breast tumors. A three-dimensional migration assay was performed to investigate the collective migration of BM-MSCs, maintaining cell-cell adhesion, toward breast tumor cells. Results: N-cadherin formed adherens junction-like structures on the intercellular borders of BM-MSCs, and TGF-β increased the expression of N-cadherin on these borders. Knockdown of Smad4 impaired the TGF-β-mediated increase in N-cadherin expression in BM-MSCs, but inhibitors of non-canonical TGF-β pathways, such as extracellular signal-regulated kinases, Akt, and p38, did not affect it. siRNA-mediated knockdown of N-cadherin and Smad4 impaired the migration of BM-MSCs in response to TGF-β. Conditioned medium from breast tumor cells also enhanced the expression of N-cadherin in BM-MSCs, but inactivation of TGF-β type 1 receptor (TGFBR1) with SB505124 and TGFBR1 knockdown abolished the increase in N-cadherin expression. BM-MSCs collectively migrated toward CM from MDA-MB-231 in vitro while maintaining cell-cell adhesion through N-cadherin. Knockdown of N-cadherin abolished the migration of BM-MSCs toward the CM from breast tumor cells. Conclusion: In the present study, we identified N-cadherin, an intrinsic transmembrane molecule in adherens junction-like structures, on BM-MSCs as a mediator for the migration of these cells toward breast tumor. The expression of N-cadherin increases on the intercellular borders of BM-MSCs through the TGF-β canonical signaling and they collectively migrate in response to breast tumor cells expressing TGF-β via N-cadherin-dependent cell-cell adhesion. We, herein, introduce a novel promising strategy for controlling and re-engineering the breast tumor microenvironment.

Keywords: N-cadherin; TGF-β.; bone marrow-derived mesenchymal stem cell; breast tumor; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / genetics
  • Antigens, CD / metabolism*
  • Benzodioxoles / pharmacology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cadherins / genetics
  • Cadherins / metabolism*
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Culture Media, Conditioned / pharmacology
  • Female
  • Humans
  • Imidazoles / pharmacology
  • Immunohistochemistry
  • Mesenchymal Stem Cells / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Pyridines / pharmacology
  • RNA, Small Interfering
  • Real-Time Polymerase Chain Reaction
  • Receptor, Transforming Growth Factor-beta Type I / antagonists & inhibitors*
  • Receptor, Transforming Growth Factor-beta Type I / genetics
  • Receptor, Transforming Growth Factor-beta Type I / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Smad4 Protein / genetics
  • Smad4 Protein / metabolism
  • Transforming Growth Factor beta / pharmacology*
  • Tumor Microenvironment / drug effects*
  • Tumor Microenvironment / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride
  • Antigens, CD
  • Benzodioxoles
  • CDH2 protein, human
  • Cadherins
  • Culture Media, Conditioned
  • Imidazoles
  • Pyridines
  • RNA, Small Interfering
  • SMAD4 protein, human
  • Smad4 Protein
  • Transforming Growth Factor beta
  • Proto-Oncogene Proteins c-akt
  • p38 Mitogen-Activated Protein Kinases
  • Receptor, Transforming Growth Factor-beta Type I
  • TGFBR1 protein, human